ARZA B, FéLEZ J, LóPEZ-ALEMANY R, et al.Identification of an epitope of alpha-enolase (a candidate plasminogen receptor) by phage display[J].Thrombosis and Haemostasis, 1997, 78(3):1097-1103.
[2]
LONGSTAFF C, MERTON R E, FABREGAS P, et al.Characterization of cell-associated plasminogen activation catalyzed by urokinase-type plasminogen activator, but independent of urokinase receptor (uPAR, CD87)[J].Blood, 1999, 93(11):3839-3846.
[3]
REDLITZ A, FOWLER B J, PLOW E F, et al.The role of an enolase-related molecule in plasminogen binding to cells[J].European Journal of Biochemistry, 1995, 227(1/2):407-415.
[4]
OSSOWSKI L, AGUIRRE-GHISO J A.Urokinase receptor and integrin partnership:coordination of signaling for cell adhesion, migration and growth[J].Current Opinion in Cell Biology, 2000, 12(5):613-620.
[5]
VON HEIJNE G, LILJESTRM P, MIKUS P, et al.The efficiency of the uncleaved secretion signal in the plasminogen activator inhibitor type 2 protein can be enhanced by point mutations that increase its hydrophobicity[J].The Journal of Biological Chemistry, 1991, 266(23):15240-15243.
[6]
LPEZ-ALEMANY R, SUELVES M, MUOZ-CNOVES P.Plasmin generation dependent on alpha-enolase-type plasminogen receptor is required for myogenesis[J].Thrombosis and Haemostasis, 2003, 90(4):724-733.
[7]
DAZ-RAMOS A, ROIG-BORRELLAS A, GARCA-MELERO A, et al.Requirement of plasminogen binding to its cell-surface receptor α-enolase for efficient regeneration of normal and dystrophic skeletal muscle[J].PLoS One, 2012, 7(12):e50477.
[8]
BRYER S C, KOH T J.The urokinase-type plasminogen activator receptor is not required for skeletal muscle inflammation or regeneration[J].American Journal of Physiology:Regulatory, Integrative and Comparative Physiology, 2007, 293(3):R1152-R1158.
[9]
HABIB S S, ABDELGADER A G, KURDI M I, et al.Tissue plasminogen activator and plasminogen activator inhibitor-1 levels in patients with acute myocardial infarction and unstable angina[J].The Journal of the Pakistan Medical Association, 2012, 62(7):681-685.
[10]
CESARMAN G M, GUEVARA C A, HAJJAR K A.An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA).Ⅱ.Annexin Ⅱ-mediated enhancement of t-PA-dependent plasminogen activation[J].The Journal of Biological Chemistry, 1994, 269(33):21198-21203.
[11]
YANG H B, ZHENG W J, ZHANG X, et al.Induction of endothelial cell apoptosis by anti-alpha-enolase antibody[J].Chinese Medical Sciences Journal, 2011, 26(3):152-157.
[12]
FEO S, ARCURI D, PIDDINI E, et al.ENO1 gene product binds to the c-myc promoter and acts as a transcriptional repressor:relationship with myc promoter-binding protein 1 (MBP-1)[J].FEBS Letters, 2000, 473(1):47-52.
[13]
LO PRESTI M, FERRO A, CONTINO F, et al.Myc promoter-binding protein-1 (MBP-1) is a novel potential prognostic marker in invasive ductal breast carcinoma[J].PLoS One, 2010, 5(9):e12961.
[14]
EJESK？R K, KRONA C, CARéN H, et al.Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death[J].BMC Cancer, 2005, 5:161.
[15]
CHEN X L, ZHOU L, YANG J, et al.Hepatocellular carcinoma-associated protein markers investigated by MALDI-TOF MS[J].Molecular Medicine Reports, 2010, 3(4):589-596.
[16]
STIERUM R, GASPARI M, DOMMELS Y, et al.Proteome analysis reveals novel proteins associated with proliferation and differentiation of the colorectal cancer cell line Caco-2[J].Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics, 2003, 1650(1/2):73-91.
